TRAIL Is Associated with Impaired Regulation of CD4+CD25- T Cells by Regulatory T Cells in Patients with Rheumatoid Arthritis

被引:35
|
作者
Xiao, Hong [2 ]
Wang, Shun [3 ]
Miao, RunSheng [1 ]
Kan, WuSheng [1 ]
机构
[1] Fourth Hosp Wuhan, Dept Orthoped, Wuhan 430000, Peoples R China
[2] Wuhan 1 Hosp, Wuhan 430000, Peoples R China
[3] Wuhan 1 Hosp, Dept Lab Med, Wuhan 430000, Peoples R China
关键词
Apoptosis; regulatory T cells; rheumatoid arthritis; TRAIL; cytokine; IMMUNOLOGICAL SELF-TOLERANCE; COLLAGEN-INDUCED ARTHRITIS; APOPTOSIS-INDUCING LIGAND; PERIPHERAL-BLOOD; EXPRESSION; DISEASE; POPULATION; RECEPTOR; ONSET; CD25;
D O I
10.1007/s10875-011-9559-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thirty-five rheumatoid arthritis (RA) patients and 27 healthy volunteers were enrolled in the study. Regulatory T (Treg) cell numbers were significantly reduced in RA patients. RA Treg cells exhibited an impaired capacity to inhibit proliferation and cytokine secretion of autologous T effector (Teff) cells. However, the crossover experiments further indicated that this impaired suppression was due to resistance of Teff cells but not to an intrinsic defect of Treg cells in RA patients. RA Teff cells showed a higher expression of membrane tumor necrosis factor-related apoptosis-inducing ligand and secreted more soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL could induce apoptosis in Treg cells. Neutralization of TRAIL restored the regulation of Teff by Treg in RA patients. In summary, our data suggest that reduced peripheral Treg cell numbers and an increased resistance of Teff cells to suppression by Treg cells were present in RA patients, and TRAIL may be an underlying mechanism for the impaired regulation of Teff cells by Treg cells.
引用
收藏
页码:1112 / 1119
页数:8
相关论文
共 50 条
  • [21] CD4+ CD25+ T regulatory cells and proinflammatory cytokines in Egyptians with rheumatoid arthritis
    Wesam S. Ibrahim
    Hanan M. El Saadany
    Manal A. Abd El khalek
    Mahamoud F. Seliem
    Egyptian Rheumatology and Rehabilitation, 2013, 40 (2) : 121 - 127
  • [22] Action of CD4+CD25+ regulatory T cells is impaired in multiple sclerosis patients
    Putzki, N
    Kumar, M
    Vago, S
    Kreuzfelder, E
    Limmroth, V
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S243 - S243
  • [23] Human ovarian carcinoma cells generate CD4+ CD25+ regulatory T cells from peripheral CD4+CD25- T cells through secreting TGF-β
    Li, Xiao
    Ye, Feng
    Chen, Huaizeng
    Lu, Weiguo
    Wan, Xiaoyun
    Xie, Xing
    CANCER LETTERS, 2007, 253 (01) : 144 - 153
  • [24] Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells
    Liu, CY
    Battaglia, M
    Lee, SH
    Sun, QH
    Aster, RH
    Visentin, GP
    JOURNAL OF IMMUNOLOGY, 2005, 174 (05): : 2680 - 2686
  • [25] Differential suppression of naive and memory human CD4+CD25- cells by naturally occurring CD4+CD25+ regulatory T cells in vitro
    Afzali, B.
    Mitchell, P. J.
    Scotta, C.
    Canavan, J.
    Edozie, F. C.
    Hernandez-Fuentes, M.
    Lechler, R. I.
    Lombardi, G.
    IMMUNOLOGY, 2010, 131 : 177 - 178
  • [26] Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells
    Unger, WWJ
    Jansen, W
    Wolvers, DAW
    van Halteren, AGS
    Kraal, G
    Samsom, JN
    INTERNATIONAL IMMUNOLOGY, 2003, 15 (06) : 731 - 739
  • [27] Bead-isolated human CN4+CD25+ T regulatory cells are anergic and significantly suppress proliferation of CD4+CD25- T responder cells
    Elkord, Eyad
    Hopcraft, Lucy
    Burt, Debbie
    Stern, Peter L.
    CLINICAL IMMUNOLOGY, 2006, 120 (02) : 232 - 233
  • [28] Global gene expression profiles of activated CD4+CD25high (regulatory) and CD4+CD25- (non-regulatory) T cells
    Liu, CY
    Sun, QH
    Visentin, GP
    BLOOD, 2005, 106 (11) : 925A - 925A
  • [29] Enrichment of regulatory CD25brightCD4+T cells in the joints of patients with rheumatoid arthritis.
    Cao, DJ
    Malmstrom, V
    Baecher-Allen, C
    Hafler, DA
    Klareskog, L
    Trollmo, C
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S69 - S69
  • [30] Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells
    Lim, Dong-Gyun
    Park, Youn-Hee
    Kim, Sung-Eun
    Kim, Yong-Hee
    Park, Chan-Sik
    Kim, Song-Cheol
    Park, Chung-Gyu
    Han, Duck-Jong
    INTERNATIONAL IMMUNOLOGY, 2011, 23 (09) : 583 - 592